Designing a recombinant chimeric construct contain MUC1 and HER2 extracellular domain for prediagnostic breast cancer

Usefulness of Traditional Serum Biomarkers for Management of Breast Cancer Patients

(2013) Peppino Mirabelli et al.   Biomed Research International

Predictive value of HER2 serum levels in patients treated with lapatinib or trastuzumab – a translational project in the neoadjuvant GeparQuinto trial

(2012) I Witzel et al.   BRITISH JOURNAL OF CANCER

Evaluation of Known Oncoantibodies, HER2, p53, and Cyclin B1, in Prediagnostic Breast Cancer Sera

(2012) H. Lu et al.   Cancer Prevention Research

Antibody Targeting of Cell-Bound MUC1 SEA Domain Kills Tumor Cells

(2012) E. Pichinuk et al.   CANCER RESEARCH

Dual Targeting of ErbB2 and MUC1 in Breast Cancer Using Chimeric Antigen Receptors Engineered to Provide Complementary Signaling

(2012) Scott Wilkie et al.   JOURNAL OF CLINICAL IMMUNOLOGY

MUC1 and MUC4: Switching the Emphasis from Large to Small

(2011) Huguette Albrecht et al.   CANCER BIOTHERAPY AND RADIOPHARMACEUTICALS

Current technologies for HER2 testing in breast cancer

(2011) C.B. Moelans et al.   CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY

The tumor macroenvironment and systemic regulation of breast cancer progression

(2011) Zafira Castaño et al.   INTERNATIONAL JOURNAL OF DEVELOPMENTAL BIOLOGY

Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evidence

(2011) Ben Zhang et al.   LANCET ONCOLOGY

Identification of early molecular markers for breast cancer

(2011) Céline Kretschmer et al.   Molecular Cancer

Cancer Biomarkers Defined by Autoantibody Signatures to Aberrant O-Glycopeptide Epitopes

(2010) H. H. Wandall et al.   CANCER RESEARCH

Detection of Circulating Anti-Mucin 1 (MUC1) Antibodies in Breast Tumor Patients by Indirect Enzyme-Linked Immunosorbent Assay Using a Recombinant MUC1 Protein Containing Six Tandem Repeats and Expressed in Escherichia coli

(2010) Y. Tang et al.   Clinical and Vaccine Immunology

Immunogenic properties of chimeric protein from espA, eae and tir genes of Escherichia coli O157:H7

(2010) Jafar Amani et al.   VACCINE

Expression of the Recombinant Major Allergen of Salsola kali Pollen (Sal k 1) and Comparison with Its Low-Immunoglobulin E-Binding Mutant

(2010) Mohammad Ali Assarehzadegan et al.   ALLERGOLOGY INTERNATIONAL

Identification of a New Panel of Serum Autoantibodies Associated with the Presence of In situ Carcinoma of the Breast in Younger Women

(2009) C. Desmetz et al.   CLINICAL CANCER RESEARCH

Current molecular diagnostics of breast cancer and the potential incorporation of microRNA

(2009) Christine K Zoon et al.   EXPERT REVIEW OF MOLECULAR DIAGNOSTICS

Breast cancer humoral immune response: involvement of Lewis y through the detection of circulating immune complexes and association with Mucin 1 (MUC1)

(2009) Marina Larrain et al.   JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH

Anti-HER2 Treatment and Breast Cancer: State of the Art, Recent Patents, and New Strategies

(2009) Lorenzo Daniele et al.   Recent Patents on Anti-Cancer Drug Discovery

Level of HER-2/neu protein expression in breast cancer may affect the development of endogenous HER-2/neu-specific immunity

(2008) V. Goodell et al.   MOLECULAR CANCER THERAPEUTICS